---
schema_version: "secwatch.filing_event.v1"
accession: "0001609550-25-000035"
form_type: "8-K"
ticker: "INSP"
cik: "0001609550"
company_name: "Inspire Medical Systems, Inc."
filed_at: "2025-08-11T23:59:59+00:00"
generated_at: "2026-05-17T15:29:01.317559+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Inspire Medical Systems board authorizes $200M share repurchase program

## Summary
- Board authorized repurchase of up to $200M of common stock.
- Program expires August 7, 2027, unless extended or terminated earlier.
- CEO cites financial strength and confidence in growth as rationale.
- Company states stock is undervalued and addressable market lightly penetrated.
- Purchases may occur via open market or private transactions; no obligation to buy specific number.

## SEC filing metadata
- accession: 0001609550-25-000035
- form_type: 8-K
- ticker: INSP
- cik: 0001609550
- company_name: Inspire Medical Systems, Inc.
- filed_at: 2025-08-11T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1609550/000160955025000035/0001609550-25-000035-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1609550/000160955025000035/insp-20250811.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001609550-25-000035
- JSON: https://secwatch.observer/filing/0001609550-25-000035.json
- Plain text: https://secwatch.observer/filing/0001609550-25-000035.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.